Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Quality of Life and Health Economic Measurements in Allergic Patients Treated With Immunotherapy (SABAL)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Karin Dam Petersen, Aalborg University
ClinicalTrials.gov Identifier:
NCT01486498
First received: December 3, 2011
Last updated: December 5, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2011
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)